Accuracy Evaluation of Four Blood Glucose Monitoring Systems in Unaltered Blood Samples in the Low Glycemic Range and Blood Samples in the Concentration Range Defined by ISO 15197.

INTRODUCTION Systems for self-monitoring of blood glucose (SMBG) are expected to be accurate enough to provide reliable measurement results. Especially in the low glycemic range, adequate therapeutic decisions based on reliable results can alleviate complications associated with hypoglycemia. MATERIALS AND METHODS The accuracy of four SMBG systems (system 1 was the ACCU-CHEK(®) Aviva [Roche Diagnostics GmbH, Mannheim, Germany], system 2 was the Contour(®) XT [Bayer Consumer Care AG, Basel, Switzerland], system 3 was the GlucoCheck XL [aktivmed GmbH, Augsberg, Germany], and system 4 was the GlucoMen(®) LX PLUS [A. Menarini Diagnostics S.r.l., Florence, Italy]) with three test-strip lots each was evaluated by calculating mean absolute relative differences (MARDs). Two datasets were evaluated: (1) 100 samples with blood glucose concentrations <70 mg/dL and (2) 100 samples distributed following International Organization for Standardization (ISO) standard 15197. Each sample was measured twice with each test-strip lot of each SMBG system. Comparison measurement results were obtained with a glucose oxidase method and a hexokinase method, both traceable according to ISO 17511. Analysis of variance of the MARD between the SMBG system and the comparison method was performed. RESULTS MARD values ranged from 4.4% to 13.4% (<70 mg/dL) and 4.8% to 8.9% (ISO 15197-distributed) and differed significantly, with systems 1 and 2 showing lower MARDs than systems 3 and 4. MARD values deviated by up to 2.5% (corresponding to a relative deviation of approximately 40%) between the two comparison methods. CONCLUSIONS The investigated SMBG systems showed a significant variation of accuracy (measured by MARD), especially with higher MARD values in the low glycemic range. The selected comparison method had an impact on the MARD and therefore on the apparent accuracy of the SMBG systems. Sufficient measurement accuracy in the low glycemic range is required to enable users to react adequately to hypoglycemia.

[1]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[2]  Jennifer Y. Liu,et al.  Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. , 2001, The American journal of medicine.

[3]  Klaus P. Ebmeier,et al.  Regional cerebral blood flow in IDDM patients: Effects of diabetes and of recurrent severe hypoglycaemia , 1994, Diabetologia.

[4]  Sverre Sandberg,et al.  Between-lot variation in external quality assessment of glucose: clinical importance and effect on participant performance evaluation. , 2005, Clinical chemistry.

[5]  T. Seppänen,et al.  Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes , 2008, Diabetologia.

[6]  Gunn B B Kristensen,et al.  Standardized evaluation of nine instruments for self-monitoring of blood glucose. , 2008, Diabetes technology & therapeutics.

[7]  Bruce W Bode,et al.  Self-Monitoring of Blood Glucose (SMBG) in insulin- and non-insulin-using adults with diabetes: consensus recommendations for improving SMBG accuracy, utilization, and research. , 2008, Diabetes technology & therapeutics.

[8]  B. Ginsberg.  Factors Affecting Blood Glucose Monitoring: Sources of Errors in Measurement , 2009, Journal of diabetes science and technology.

[9]  D. Newby,et al.  Effects of Acute Insulin-Induced Hypoglycemia on Indices of Inflammation , 2010, Diabetes Care.

[10]  C. Byrne,et al.  Acute Hypoglycemia Decreases Myocardial Blood Flow Reserve in Patients With Type 1 Diabetes Mellitus and in Healthy Humans , 2011, Circulation.

[11]  I. Saul,et al.  Recurrent Hypoglycemia Exacerbates Cerebral Ischemic Damage in Streptozotocin-Induced Diabetic Rats , 2011, Stroke.

[12]  H. Bilo,et al.  Self-Monitoring of Blood Glucose: The Use of the First or the Second Drop of Blood , 2011, Diabetes Care.

[13]  Ryuzo Kawamori,et al.  Glucose Monitoring After Fruit Peeling: Pseudohyperglycemia When Neglecting Hand Washing Before Fingertip Blood Sampling , 2011, Diabetes Care.

[14]  Christina Schmid,et al.  Lot-to-Lot Variability of Test Strips and Accuracy Assessment of Systems for Self-Monitoring of Blood Glucose according to ISO 15197 , 2012, Journal of diabetes science and technology.

[15]  Andreas Pfützner,et al.  Accuracy evaluation of five blood glucose monitoring systems obtained from the pharmacy: a European multicenter study with 453 subjects. , 2012, Diabetes technology & therapeutics.

[16]  Richard Hellman,et al.  Glucose meter inaccuracy and the impact on the care of patients , 2012, Diabetes/metabolism research and reviews.

[17]  R. Wadwa,et al.  Hypoglycemia, diabetes, and cardiovascular disease. , 2012, Diabetes technology & therapeutics.

[18]  Andreas Pfützner,et al.  Clinical assessment of the accuracy of blood glucose measurement devices , 2012, Current medical research and opinion.

[19]  Joan Lee Parkes,et al.  Accuracy Evaluation of Five Blood Glucose Monitoring Systems: The North American Comparator Trial , 2013, Journal of diabetes science and technology.

[20]  Guido Freckmann,et al.  Performance Evaluation of Three Continuous Glucose Monitoring Systems: Comparison of Six Sensors Per Subject in Parallel , 2013, Journal of diabetes science and technology.

[21]  E. Budiman,et al.  Clinical Implications and Economic Impact of Accuracy Differences among Commercially Available Blood Glucose Monitoring Systems , 2013, Journal of diabetes science and technology.

[22]  G. Freckmann,et al.  Partial Pressure of Oxygen in Capillary Blood Samples from the Fingertip , 2013, Journal of diabetes science and technology.

[23]  E. Budiman,et al.  Continuous Glucose Monitoring in the Subcutaneous Tissue over a 14-Day Sensor Wear Period , 2013, Journal of diabetes science and technology.

[24]  System accuracy of blood glucose monitoring systems: impact of use by patients and ambient conditions. , 2013, Diabetes technology & therapeutics.

[25]  Ronald Brazg,et al.  Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor. , 2014, Diabetes technology & therapeutics.

[26]  Marc D. Breton,et al.  Effect of Algorithm Aggressiveness on the Performance of the Hypoglycemia-Hyperglycemia Minimizer (HHM) System , 2014, Journal of diabetes science and technology.

[27]  Steven J. Russell,et al.  A Comparative Effectiveness Analysis of Three Continuous Glucose Monitors , 2014, Journal of diabetes science and technology.

[28]  Bruce A. Buckingham,et al.  Accuracy Evaluation of Blood Glucose Monitoring Systems in Children on Overnight Closed-Loop Control , 2014, Journal of diabetes science and technology.

[29]  Richard F Louie,et al.  Computing the Surveillance Error Grid Analysis , 2014, Journal of diabetes science and technology.

[30]  Ronald Brazg,et al.  Accuracy evaluation of contour next compared with five blood glucose monitoring systems across a wide range of blood glucose concentrations occurring in a clinical research setting. , 2015, Diabetes technology & therapeutics.